U. Gayko

发表

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

J. Leonard, S. Ely, A. Cesano, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia (AML): Validation in Two Independent Sample Sets from ECOG and SWOG Trials

J. Radich, D. Spellmeyer, F. Appelbaum, 2012 .

Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.

S. Clarke, J. Zalcberg, J. Gutheil, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD22 as a target of passive immunotherapy.

A. Cesano, U. Gayko, 2003, Seminars in oncology.

Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies

S. Zhuang, F. Clow, Steven Sun, 2015, Annals of the New York Academy of Sciences.

Signaling changes in the stem cell factor–AKT-S6 pathway in diagnostic AML samples are associated with disease relapse

W. Fantl, A. Cesano, S. Putta, 2011, Blood cancer journal.

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

A. Saven, S. Brosman, R. Bukowski, 2001, British Journal of Cancer.

Phase I /II T rial o f E pratuzumab ( Humanized A nti-CD22 Antibody) i n I ndolent N on-Hodgkin's L ymphoma

J. Leonard, S. Ely, A. Cesano, 2003 .

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.

S. Clarke, J. Zalcberg, J. Gutheil, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional Pathway Analysis Using SCNP of FLT3 Receptor Pathway Deregulation in AML Provides Prognostic Information Independent from Mutational Status

M. Tallman, L. Cripe, R. Hawtin, 2013, PloS one.

Identification of metalloprotease/disintegrins in Xenopus laevis testis with a potential role in fertilization.

G. Weskamp, C. Blobel, H. Cai, 1997, Developmental biology.

Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group

S. Meshinchi, T. Alonzo, R. Gerbing, 2013, British journal of haematology.

Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)

M. Minden, W. Fantl, S. Kornblau, 2010, PloS one.

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

J. Leonard, A. Cesano, D. Goldenberg, 2004, Clinical Cancer Research.

Synergistic activities of multiple phosphotyrosine residues mediate full signaling from the Drosophila Torso receptor tyrosine kinase.

N. Perrimon, D. Morrison, T. Copeland, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Temperature-sensitive control of protein activity by conditionally splicing inteins

Norbert Perrimon, Yohanns Bellaiche, N. Perrimon, 2004, Nature Biotechnology.

Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: Effect of specimen source (bone marrow or peripheral blood) on assay readouts

H. Uno, D. Spellmeyer, M. Tallman, 2012, Cytometry. Part B, Clinical cytometry.

Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy

M. Minden, D. Spellmeyer, W. Fantl, 2010, Clinical Cancer Research.

Dynamic single cell network profiles in AML are associated with patient response to standard induction therapy Running Title: SCNP in AML Induction Therapy Response

M. Minden, D. Spellmeyer, W. Fantl, 2010 .

Drosophila terminal structure development is regulated by the compensatory activities of positive and negative phosphotyrosine signaling sites on the Torso RTK.

N. Perrimon, D. Morrison, L. Perkins, 1996, Genes & development.

FLT3 ITD signaling profiles in AML samples harboring mutations

M. Minden, W. Fantl, A. Cesano, 2010 .

Initial results of a pilot study of epratuzumab and rituximab in combination with CHOP chemotherapy (ER-CHOP) in previously untreated patients with diffuse large B-cell lymphoma (DLBCL).

T. Habermann, S. Horning, S. Ansell, 2004, Journal of Clinical Oncology.

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia

J. Radich, D. Spellmeyer, F. Appelbaum, 2015, PloS one.

Single Cell Network Profiling (SCNP) Signatures Predict Response to Induction Therapy and Relapse Risk In Pediatric Patients with Acute Myeloid Leukemia: Children's Oncology Group (COG) Study POG-9421

S. Raimondi, R. Arceci, S. Meshinchi, 2010 .

Sample Cryopreservation Does Not Affect Functional Read Outs In SCNP Assays: Implications for Biomarker Development

S. Kornblau, A. Cesano, J. Gotlib, 2010 .